An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Cancer Research

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-1258PMID 19118056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostics. Amid debate, gene-based cancer test approved.

  2007cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Three-gene prognostic classifier for early-stage non small-cell lung cancer.

  2007cited by this paper
• Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

  2007cited by this paper
• A Translational View of the Molecular Pathogenesis of Lung Cancer

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007influential reference
• A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

  2006cited by this paper
• Concordance among gene-expression-based predictors for breast cancer.

  2006cited by this paper
• Multiple robust signatures for detecting lymph node metastasis in head and neck cancer.

  2006cited by this paper
• Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

  2006cited by this paper
• Converting a breast cancer microarray signature into a high-throughput diagnostic test

  2006cited by this paper
• Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma

  2006cited by this paper
• Management of early-stage lung cancer: past, present, and future adjuvant trials.

  2006cited by this paper
• A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• BMC Genomics BioMed Central Methodology article

  2005cited by this paper
• An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas

  2005cited by this paper
• Prediction of cancer outcome with microarrays: a multiple random validation strategy.

  2005cited by this paper
• Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion

  2005cited by this paper
• Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

  2004cited by this paper
• The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use

  2004cited by this paper
• Rules of evidence for cancer molecular-marker discovery and validation

  2004cited by this paper
• Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

  2003cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Gene-expression profiles predict survival of patients with lung adenocarcinoma

  2002cited by this paper
• Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

  2001cited by this paper

• Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancer.

  2024cites this paper
• Identification of Two Subtypes with Distinct Immune Features in Lung Adenocarcinoma by Utilizing Immune and Metabolism-Related Genes to Assist Immunotherapy.

  2024cites this paper
• Systematically analyzed molecular characteristics of lung adenocarcinoma using metabolism-related genes classification

  2023cites this paper
• Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy and chemoimmunotherapy in resectable NSCLC.

  2022cites this paper
• A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer

  2022cites this paper
• Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors

  2022cites this paper
• Group-Sparse SVD Models via <inline-formula><tex-math notation="LaTeX">$L_1$</tex-math><alternatives><mml:math><mml:msub><mml:mi>L</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="zhang-ieq1-2932063.gif"/></alternatives></inline-formula>- and <inline-formula><tex-math nota

  2021cites this paper
• Multiomic Characterization of Stage I Lung Adenocarcinoma Reveals Distinct Genetic and Immunologic Features of Recurrent Disease

  2021cites this paper
• Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma

  2021cites this paper
• An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma

  2021cites this paper
• Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management

  2021cites this paper
• Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay

  2021cites this paper
• A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer

  2021cites this paper
• Identification of prognostic signature of non–small cell lung cancer based on TCGA methylation data

  2020cites this paper
• OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer

  2020cites this paper
• Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer

  2020cites this paper
• CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction.

  2020cites this paper
• A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer

  2019cites this paper
• Weighted gene expression profiles identify diagnostic and prognostic genes for lung adenocarcinoma and squamous cell carcinoma

  2019cites this paper
• Prediction of response to anti-cancer drugs becomes robust via network integration of molecular data

  2019cites this paper
• T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

  2019cites this paper
• Large-scale gene expression analysis reveals robust gene signatures for prognosis prediction in lung adenocarcinoma

  2019cites this paper
• Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.

  2019cites this paper
• A novel protein‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patients

  2018cites this paper
• A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia

  2018cites this paper
• Signaling protein signature predicts clinical outcome of non-small-cell lung cancer

  2018cites this paper
• A Risk Stratification Model for Lung Cancer Based on Gene Coexpression Network and Deep Learning

  2018cites this paper
• Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.

  2018cites this paper
• Robust and clinically relevant prediction of response to anti-cancer drugs via network integration of molecular profiles

  2018cites this paper
• 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

  2018cites this paper
• Molecular Staging and Prognosis in Lung Cancer Estadificación y pronóstico molecular del cáncer de pulmón

  2018cites this paper
• Group-sparse SVD Models and Their Applications in Biological Data

  2018cites this paper
• Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model

  2018cites this paper
• Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms

  2018cites this paper
• A risk stratification model for lung cancer based on gene coexpression network

  2017cites this paper
• Molecular Basis of Lung Carcinogenesis

  2017cites this paper
• Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

  2017cites this paper
• Identification of early-stage lung adenocarcinoma prognostic signatures based on statistical modeling

  2017cites this paper
• Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients

  2017cites this paper
• Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies

  2017cites this paper
• Non–Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications

  2017cites this paper
• Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC1

  2017cites this paper
• NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

  2017cites this paper
• Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC 1

  2017cites this paper
• Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers

  2016cites this paper
• A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes

  2016cites this paper
• Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets.

  2016cites this paper
• High-dimensional genomic data bias correction and data integration using MANCIE

  2016cites this paper
• [Difficulties and limitations in conducting translational research in thoracic oncology. A practical example].

  2016cites this paper
• Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients

  2016cites this paper
• Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer

  2016cites this paper
• The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

  2015cites this paper
• A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

  2015cites this paper
• CD8(high)CD57(+) T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer.

  2015cites this paper
• Commercially available prognostic molecular models in early-stage lung cancer: a review of the Pervenio Lung RS and Myriad myPlan Lung Cancer tests

  2015influential citation
• Validation of Intratumoral T-bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer

  2015cites this paper
• 1 Validation of Intratumoral T-bet + Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer

  2015cites this paper
• Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.

  2015cites this paper
• EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas

  2015cites this paper
• Gene Expression Profiling for Early-stage NSCLC

  2015cites this paper
• miRNA Analysis by Next-Generation Sequencing and its Prognostic Importance in Non-Small Cell Lung Cancer

  2015cites this paper
• Facteurs pronostiques et cancers bronchopulmonaires

  2015cites this paper
• Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma

  2014influential citation
• The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts

  2014cites this paper
• Highlight report: Validation of prognostic genes in lung cancer

  2014cites this paper
• Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers

  2014cites this paper
• Cancer research: from prognostic genes to therapeutic targets

  2014cites this paper
• Biology of Human Tumors Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Speci fi c Molecular Entity

  2014cites this paper
• CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes

  2014cites this paper
• Semi-supervised linear discriminant analysis through moment-constraint parameter estimation

  2014cites this paper
• Sparse principal component analysis in cancer research.

  2014cites this paper
• Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

  2014cites this paper
• Non–Small-Cell Lung Cancer After Breast Cancer: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes in 3529 Women

  2014cites this paper
• Prognostic and Predictive Biomarker Signatures

  2014cites this paper
• Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer

  2014cites this paper
• Identificación mediante inmunohistoquímica de factores pronósticos biomoleculares en el carcinoma broncogénico no microcítico en estadio precoz resecado

  2014cites this paper
• Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients

  2014cites this paper
• Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use

  2014cites this paper
• Peripheral Immune Cell Gene Expression Changes in Advanced Non-Small Cell Lung Cancer Patients Treated with First Line Combination Chemotherapy

  2013cites this paper
• Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines

  2013cites this paper
• Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients

  2013influential citation
• Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?

  2013cites this paper
• Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis

  2013cites this paper
• Yin Yang Gene Expression Ratio Signature for Lung Cancer Prognosis

  2013cites this paper
• Integrative Genomics Analysis Identifies Candidate Drivers at 3q26-29 Amplicon in Squamous Cell Carcinoma of the Lung

  2013cites this paper
• Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing

  2013cites this paper
• Small Cell Lung Cancer Patients − Chemotherapy in Non A 12-Gene Set Predicts Survival Benefits from Adjuvant

  2013cites this paper
• When Is Hub Gene Selection Better than Standard Meta-Analysis?

  2013cites this paper
• Analytical Validation of a Practical Molecular Assay Prognostic of Survival in Nonsquamous Non–Small Cell Lung Cancer

  2013cites this paper
• Update on recent prognostic markers in adenocarcinoma

  2013cites this paper
• Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.

  2013cites this paper
• A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

  2013cites this paper
• Lung Cancer Gene Signatures and Clinical Perspectives

  2013cites this paper
• Identification of consensus modules in Adenocarcinoma data

  2012cites this paper
• A lung cancer molecular prognostic test ready for prime time.

  2012cites this paper
• A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors

  2012cites this paper
• The peripheral immune response and lung cancer prognosis

  2012cites this paper
• A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#

  2012cites this paper
• eff ect of increasing prevalence of chronic kidney disease on the future needs of their populations.

  2012cites this paper
• L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer

  2012cites this paper